Profil
John McCafferty is the founder and Chief Technology Officer of Maxion Therapeutics Ltd., which was founded in 2020.
He is also the founder and Chief Scientific Officer of IONTAS Ltd.
(United Kingdom), which was founded in 2012.
Aktive Positionen von John McCafferty
Unternehmen | Position | Beginn |
---|---|---|
IONTAS Ltd. (United Kingdom)
IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Part of Fairjourney Biologics SA, IONTAS Ltd. is a British company that provides antibody discovery services. The company is based in Cambridge, UK. The company was founded by John McCafferty. António Bernadino Guimaraes Parada has been the CEO of the company since 2020. IONTAS Ltd. (United Kingdom) was acquired by Fairjourney Biologics SA on May 13, 2020. | Gründer | 01.01.2012 |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Gründer | 16.04.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
IONTAS Ltd. (United Kingdom)
IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Part of Fairjourney Biologics SA, IONTAS Ltd. is a British company that provides antibody discovery services. The company is based in Cambridge, UK. The company was founded by John McCafferty. António Bernadino Guimaraes Parada has been the CEO of the company since 2020. IONTAS Ltd. (United Kingdom) was acquired by Fairjourney Biologics SA on May 13, 2020. | Health Technology |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Health Technology |